Parasites and Immunotherapy: With or Against?

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Parasites and Immunotherapy: With or Against? Publisher

Yousofi Darani H¹ ; Yousefi M² ; Safari M³ ; Jafari R⁴

Source: Journal of Parasitic Diseases Published:2016

Abstract

Immunotherapy is a sort of therapy in which antibody or antigen administrates to the patient in order to treat or reduce the severity of complications of disease. This kind of treatment practiced in a wide variety of diseases including infectious diseases, autoimmune disorders, cancers and allergy. Successful and unsuccessful immunotherapeutic strategies have been practiced in variety of parasitic infections. On the other hand parasites or parasite antigens have also been considered for immunotherapy against other diseases such as cancer, asthma and multiple sclerosis. In this paper immunotherapy against common parasitic infections, and also immunotherapy of cancer, asthma and multiple sclerosis with parasites or parasite antigens have been reviewed. © 2014, Indian Society for Parasitology.

Related Docs

View other Related Docs

1. Parasites and Cancers: Parasite Antigens As Possible Targets for Cancer Immunotherapy, Future Oncology (2012)

2. Effect of Hydatid Cyst Antigens Polyspecific Antisera on Breast Cancer Cells (4T1) Growth in Cell Culture Medium, International Journal of Environmental Health Engineering (2022)

3. Low Titer of Antibody Against Toxoplasma Gondii May Be Related to Resistant to Cancer, Journal of Cancer Research and Therapeutics (2015)

Experts (# of related papers)

View all Related Experts

Hossein Yousofi Darani (14)

Mohammad Reza Mofid (4)

Other Related Docs

4. Mutual Action of Anticancer and Antiparasitic Drugs: Are There Any Shared Targets?, Future Oncology (2014)

5. Parasites As Potential Targets for Cancer Immunotherapy, Journal of Cancer Research and Clinical Oncology (2023)

6. Anti-Cancer Immunoprotective Effects of Immunization With Hydatid Cyst Wall Antigens in a Non-Immunogenic and Metastatic Triple-Negative Murine Mammary Carcinoma Model, International Immunopharmacology (2021)

7. Effect of Alive Protoscoleces of Hydatid Cyst on the Growth of Melanoma Cells in Mouse Model, Journal of Isfahan Medical School (2014)

8. Vaccination in Leishmaniasis: A Review Article, Iranian Biomedical Journal (2022)

9. Effect of Two Hydatid Cyst Antigens on the Growth of Melanoma Cancer in C57/Black Mice, Journal of Parasitic Diseases (2016)

10. Identifying the Most Effective Hydatid Cyst Fluid Fraction for Anticancer Vaccination of 4T1 Breast Tumor-Bearing Mice, International Journal of Preventive Medicine (2019)

11. Inhibition of Mouse Colon Cancer Growth Following Immunotherapy With a Fraction of Hydatid Cyst Fluid, Experimental Parasitology (2023)

12. Monoclonal Antibodies Production Against a 40Kda Band of Hydatid Cyst Fluid, Recent Patents on Biotechnology (2018)

13. Effects of Toxoplasma Gondii and Toxocara Canis Antigens on Wehi-164 Fibrosarcoma Growth in a Mouse Model, Korean Journal of Parasitology (2009)

14. Anti-Toxoplasma Gondii Antibodies Attach to Mouse Cancer Cell Lines But Not Normal Mouse Lymphocytes, Biomedical Reports (2019)

15. Effect of Hydatid Cyst Antigens on Inhibition of Melanoma Cancer Growth in Mouse Model, Cellular and Molecular Biology (2018)

16. A Systematic Review of Toxoplasma Gondii Antigens to Find the Best Vaccine Candidates for Immunization, Microbial Pathogenesis (2019)

17. Review of the Prevalence and Causes of Antimony Compounds Resistance in Different Societies: Review Article, Tehran University Medical Journal (2017)

18. Intestinal Parasites Associated With Opportunistic Coccidial Infections Among Immunocompromised Individuals in Central Iran: A Cross Sectional Study, Archives of Clinical Infectious Diseases (2019)

19. The Seroprevalence of Anti-Toxoplasma Gondii Igg and Igm Antibodies in Serum Samples Referred to Educational Hospitals of Abadan, Journal of Isfahan Medical School (2022)

20. Evaluation of Th17 Immune Responses of Recombinant Dna Vaccine Encoding Gra14 and Rop13 Genes Against Toxoplasma Gondii in Balb/C Mice, Infection, Genetics and Evolution (2021)

Style	Citing Format
MLA	Yousofi Darani H, et al.. "Parasites and Immunotherapy: With or Against?." Journal of Parasitic Diseases, vol. 40, no. 2, 2016, pp. 217-226.
APA	Yousofi Darani H, Yousefi M, Safari M, Jafari R (2016). Parasites and Immunotherapy: With or Against?. Journal of Parasitic Diseases, 40(2), 217-226.
Chicago	Yousofi Darani H, Yousefi M, Safari M, Jafari R. "Parasites and Immunotherapy: With or Against?." Journal of Parasitic Diseases 40, no. 2 (2016): 217-226.
Harvard	Yousofi Darani H et al. (2016) 'Parasites and Immunotherapy: With or Against?', Journal of Parasitic Diseases, 40(2), pp. 217-226.
Vancouver	Yousofi Darani H, Yousefi M, Safari M, Jafari R. Parasites and Immunotherapy: With or Against?. Journal of Parasitic Diseases. 2016;40(2):217-226.
BibTex	@article{ author = {Yousofi Darani H and Yousefi M and Safari M and Jafari R}, title = {Parasites and Immunotherapy: With or Against?}, journal = {Journal of Parasitic Diseases}, volume = {40}, number = {2}, pages = {217-226}, year = {2016} }
RIS	TY - JOUR AU - Yousofi Darani H AU - Yousefi M AU - Safari M AU - Jafari R TI - Parasites and Immunotherapy: With or Against? JO - Journal of Parasitic Diseases VL - 40 IS - 2 SP - 217 EP - 226 PY - 2016 ER -

Science Communicator Platform

Authors

Abstract